Physician profile
Joshua Moore
NPI 1669737417
$20,281.19
in general payments reported to CMS, 2019-2025
14 companies · $3,287 in 2025
The $3,287 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13K · 2024: $4,303 · 2025: $3,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $3,484 · Food and Beverage: $3,288 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,500.00 |
| Travel and Lodging | $3,484.22 |
| Food and Beverage | $3,288.23 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,367.58 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $1,017.02 | 2023-2025 | Phasix Mesh |
| Biotissue Holdings INC. | $686.90 | 2024 | |
| Kerecis Limited | $334.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $298.94 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Enform Preperitoneal Biomaterial |
| Access Pro Medical, LLC | $140.31 | 2025 | Matriderm |
| Tela Bio, INC. | $120.66 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Medtronic, INC. | $86.97 | 2025 | Maxtack, Signia |
| Smith+Nephew, INC. | $57.22 | 2023-2025 | Oasis, Stravix Pl, Grafix Pl |
| Acera Surgical, INC. | $56.27 | 2025 | Restrata Wound Matrix |
| Novo Nordisk INC | $36.69 | 2023-2024 | |
| Conmed Corporation | $31.90 | 2025 | Airseal, Conmed Handheld Instruments |
| Becton, Dickinson and Company | $27.17 | 2024 | Phasix Mesh |
| Karl Storz Endoscopy-America | $18.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.